483
Gland Pharma LimitedGland Pharma Limited – FDA 483, May 16, 2019
Record Details
An FDA inspection of Gland Pharma Limited, a parenteral drug manufacturer, revealed significant deficiencies across multiple areas. The firm failed to adequately investigate unexplained discrepancies, including visible foreign materials in drug products and issues with unclean glassware. Additionally, the inspection identified shortcomings in aseptic processing environmental monitoring, equipment cleaning and sanitization procedures, and contamination control during material transfers.
View Company Profile
ID · 4fa4ef18-c157-4399-965f-8e1c149ad245
Other documents for Gland Pharma Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.